Page 67 - Described Pythonart News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Described pythonart. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Described Pythonart Today - Breaking & Trending Today

Broking firm Pegasus Markets fined $200,000 for 'blatant' financial register breaches


Broking firm Pegasus Markets fined $200,000 for blatant financial register breaches
11 Jan, 2021 07:32 PM
4 minutes to read
A judge says Pegasus Markets offending risked undermining NZ s financial markets regime and reputation. Photo / Greg Bowker
A judge says Pegasus Markets offending risked undermining NZ s financial markets regime and reputation. Photo / Greg Bowker
A derivatives broking and trading firm has been fined $200,000 for what a judge described as deliberate and blatant lies involving New Zealand s Financial Service Providers Register.
In what is just one of a handful
such prosecutions in the country, Pegasus Markets Ltd was charged by the Financial Markets Authority (FMA) in February 2018 with breaching the Financial Service Providers (Registration and Dispute Resolution) Act (FSP Act). ....

South Island , New Zealand General , New Zealand , Comunidad Autonoma De Cataluna , Rafael Ruiz Lemonche , Garry James Patterson , Rene Moorby , June Jelas , Zealand Financial Service Providers Register , Waitakere District Court , Financial Service Providers Register , Financial Markets Authority , Morgan Devere Corporate Finance Ltd , Financial Service Providers Registration , Companies Office , Wellington District Court , Pegasus Markets Ltd , Financial Service Providers , Dispute Resolution , Judge June Jelas , Michael Reps , Pegasus Markets , Judge Jelas , New Zealand Based , தெற்கு தீவு , புதியது ஜீலாந்து ஜநரல் ,

DiosCURE to Develop Highly Specific Single-Chain Antibodies Against SARS-CoV-2, Lead Candidates Described in Science Publication


DiosCURE to Develop Highly Specific Single-Chain Antibodies Against SARS-CoV-2, Lead Candidates Described in Science Publication
Core technology includes promising bivalent single-domain antibodies simultaneously targeting two surface structures of the viral spike protein.
Lead candidates DIOS-202 and DIOS-203 are engineered for high potency and their potential to avoid the emergence of escape mutants.
DIOS-202 and DIOS-203 entered into accelerated development to initiate clinical studies later this year.
DiosCURE Therapeutics SE announced a publication in Science describing its core technology of multivalent single-chain antibodies with a unique molecular mode-of-action to inactivate SARS-CoV-2 virions. An international team led by scientists at the University of Bonn developed and characterized the lead candidates, which are exclusively licensed by DiosCURE. ....

Nordrhein Westfalen , Karolinska Institutet , Kostenloser Wertpapierhandel , Eicke Latz , Sophia Hergenhan , Klaus Wilgenbus , University Hospital Of The Bonn , Scripps Research Institute , University Of Bonn , Trophic Communications , Institute Of Innate Immunity , Chief Executive Officer , University Hospital , Innate Immunity , Core Facility Nanobodies , Executive Officer , னோற்ர்ேன் வெஸ்ட்ஃபாலன் , பல்கலைக்கழகம் மருத்துவமனை ஆஃப் தி பொன் , ஸ்கிரிப்ட்கள் ஆராய்ச்சி நிறுவனம் , பல்கலைக்கழகம் ஆஃப் பொன் , நிறுவனம் ஆஃப் உள்ளார்ந்த நோய் எதிர்ப்பு சக்தி , தலைமை நிர்வாகி அதிகாரி , பல்கலைக்கழகம் மருத்துவமனை , உள்ளார்ந்த நோய் எதிர்ப்பு சக்தி , நிர்வாகி அதிகாரி , வழி நடத்து ,